AMICOR Preserve: Fabry Disease

Developed under the direction and sponsorship of Sanofi Genzyme.

Testing for Fabry Disease

In patients with unexplained HCM, testing is carried out with the HCM panel that includes the GLA gene

Recommended diagnostic pathway1

VUS, variant of unknown significance.

When you diagnose one patient, you allow for earlier identification of other family members

For every index patient diagnosed, an average of 5 additional affected family members may be identified.2

Fabry disease is an X-linked disorder that can be passed on by both males and females3-6

You may help shorten the long diagnostic journey for people living with Fabry

AMICOR Preserve